Yale School of Medicine is advancing CAR-T therapy beyond oncology, initiating clinical trials for autoimmune diseases such as lupus, multiple sclerosis, and scleroderma. This innovative approach could reshape treatment paradigms for these conditions.
A once futuristic-sounding cancer treatment that involves extracting a patient’s own immune cells, re-engineering them to recognize tumor targets, and returning them to the body is beginning to move beyond oncology. At Yale School of Medicine (YSM), physician-scientists are testing CAR-T (chimeric antigen receptor-T cell) therapy in clinical trials for autoimmune diseases ... A once futuristic-sounding cancer treatment that involves extracting a patient’s own immune cells, re-engineering them to recognize tumor targets, and returning them to the body is beginning to move beyond oncology. At Yale School of Medicine (YSM), physician-scientists are testing CAR-T (chimeric antigen receptor-T cell) therapy in clinical trials for autoimmune diseases including lupus, multiple sclerosis (MS), and scleroderma. Yale researchers are testing CAR-T therapy in clinical trials for autoimmune diseases including lupus, multiple sclerosis, and scleroderma. They're also working Teams from hematology-oncology, rheumatology, and neurology have come together to study CAR-T therapy for MS, scleroderma, and lupus in clinical trials. The program launched in August 2025 when the first patient with MS received CAR-T cells. Earlier this year, Yale clinicians performed the first CAR-T infusion for lupus in the state. ... Multiple sclerosis is an immune-mediated disease in which the body’s own immune cells mistakenly attack the brain and spinal cord, damaging the protective myelin that allows nerve cells to communicate. That limitation is central to the work of Yale’s Erin Longbrake, MD, PhD, associate professor of neurology and principal investigator of an early-phase clinical trial testing whether CAR-T therapy can eliminate disease-driving immune cells not only in the bloodstream, but throughout the body—including the brain.
Original title: “Enhancing CAR-T Therapy: From Cancer to Autoimmune Diseases | Yale School of Medicine”